SKIP TO MAIN CONTENT

new melanoma drug – just listed on the pharmaceutical benefits scheme

Acral lentiginous melanoma of the sole, level 1. (Photo by: BSIP/Universal Images Group via Getty Images)
Acral lentiginous melanoma of the sole, level 1. Source: Getty Images

A new treatment listed on the Pharmaceutical Benefits Scheme is said to reduce the recurrence of melanoma for half of stage three cancer patients


Published

By Charitha Adikari

Source: SBS



Skip to podcast episode content

A new treatment listed on the Pharmaceutical Benefits Scheme is said to reduce the recurrence of melanoma for half of stage three cancer patients



Latest podcast episodes

Follow SBS Sinhala

Download our apps

Listen to our podcasts

Get the latest with our exclusive in-language podcasts on your favourite podcast apps.

Watch on SBS

SBS World News

Take a global view with Australia's most comprehensive world news service

Stream now